Several gene faults or genetic conditions can increase ovarian cancer risk. This includes a fault in the: BRCA 1 or BRCA 2 gene RAD51C or RAD51D gene BRIP1 gene PALB2 gene Having one of these faulty ...

Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022 Demand for germline hereditary cancer genetic testing has ...

Medically reviewed by Archana Sharma, DO The exact cause or causes of triple-negative breast cancer are unknown, but researchers have linked it to mutations in the BRCA1 and BRCA2 genes. They also ...